| Literature DB >> 32832551 |
Lingyuan Yang1,2, Lingmei Zhang1,2, Xingguo Huang1,2, Yulong Yin2,3, Tiejun Li2,3, Jiashun Chen1,2,3.
Abstract
A systemic design was carried out to investigate the optimal combination of BET, Met-Cr, CLA, and CS for improving the meat tenderness in rats. A total of 104 six-week old male Sprague-Dawley rats were randomly assigned to 13 treatments with 4 replicates of 2 rats each. The experiments lasted for 5 weeks. The results showed that inclusion of Met-Cr decreased the contents of intramuscular fat (IMF), fat among muscle cells, and lipid droplets inside muscle cells (P < 0.05), and inclusion of CLA or Met-Cr increased the contents of IMF, fat among muscle cells, and lipid droplets inside muscle cells (P < 0.05). CS increased the contents of total collagen (TC) and soluble collagen (SC), and CLA decreased the contents of TC and SC (P < 0.05). The combination of BET and CLA increased IMF and SC contents and decreased TC contents (P < 0.05). The combination of BET and CS could increase fat contents among muscle cells and decrease TC and SC contents (P < 0.05). The combination of CLA and Met-Cr decreased IMF contents (P < 0.05). The combination of CLA and CS, as well as Met-Cr and CS, decreased fat contents among muscle cells (P < 0.05). These combinations may regulate lipogenesis and decrease the deposition of fat in muscles. There existed a significant positive correlation between IMF and SC content, which might indicate that IMF content improves meat's tenderness partly by increasing SC content in muscle.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32832551 PMCID: PMC7429771 DOI: 10.1155/2020/5159796
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Composition of the basal diet, as-fed basis.
| Ingredients (g/kg) | Nutrientsa | ||
|---|---|---|---|
| Corn | 270.0 | Dry material (g/kg) | 852.2 |
| Soy bean meal | 170.0 | Total energy (MJ/kg) | 17.79 |
| Wheat | 310.0 | Crude protein (g/kg) | 206.7 |
| Wheat bran | 45.0 | Ether extract (g/kg) | 92.5 |
| Fish meal | 150.0 | Crude fiber (g/kg) | 28.9 |
| Soy oil | 10.0 | Ash (g/kg) | 59.5 |
| Lard | 30.0 | Calcium (g/kg) | 13.2 |
| Salt | 5.0 | Phosphorus (g/kg) | 6.0 |
| Limestone | 10.0 | ||
| Premixb | 10.0 |
aAnalysed values for all dietary components. bAmount provided per kilogram of diet: Cu—13 mg; Fe—270 mg; Mn—64 mg; Zn—70 mg; I—0.8 mg; Se—0.27 mg; Co—0.6 mg; vitamin A—14000 IU; vitamin D3—1500 IU; vitamin E—120 IU; vitamin K3—5 mg; thiamine—13 mg; riboflavin—12 mg; pyridoxine—12 mg; vitamin B12—0.022 mg; biotin—0.2 mg; D-pantothenic acid—24 mg; folic acid—6 mg; niacin—60 mg; choline—1250 mg.
Combination of BET, CLA, Met-Cr, and CS in each treatment based on uniform form design.
| Treatmentsa | Net content of each additive (mg/kg diet)b | Sample number | |||
|---|---|---|---|---|---|
| BET | CLA | Met-Cr | CS | ||
| 1 | 800 | 1000 | 0 | 40 | 8 |
| 2 | 1600 | 1000 | 0.8 | 20 | 8 |
| 3 | 3200 | 0 | 0.1 | 0 | 8 |
| 4 | 400 | 4000 | 0.4 | 0 | 8 |
| 5 | 1600 | 8000 | 0 | 20 | 8 |
| 6 | 3200 | 4000 | 0.05 | 160 | 8 |
| 7 | 0 | 2000 | 0.05 | 10 | 8 |
| 8 | 6400 | 16000 | 0.2 | 10 | 8 |
| 9 | 6400 | 2000 | 0.4 | 80 | 8 |
| 10 | 400 | 0 | 0.2 | 160 | 8 |
| 11 | 0 | 16000 | 0.1 | 80 | 8 |
| 12 | 800 | 8000 | 0.8 | 40 | 8 |
| 13 | 0 | 0 | 0 | 0 | 8 |
aTreatment 13 was used as a negative control, and it was not included in the uniform design. bBET: betaine; CLA: conjugated linoleic acid; Met-Cr: methionine chromium; CS: cysteamine.
Effects of BET, CLA, Met-Cr, and CS as well as their interactions on some important meat quality indices.
| Treatment | IMF (%) | TC (mg/g) | SC (mg/g) | Fat content among muscle cells | Lipid droplet content in muscle cells |
|---|---|---|---|---|---|
| 1 | 6.55a,b | 4.71a | 1.24 | 0.0024a,b | 0.0559a |
| 2 | 8.00b | 4.91a | 1.41 | 0.0035a,b | 0.0114c |
| 3 | 6.27a,b | 4.14a,b | 1.63 | 0.0033a,b | 0.03379a,b |
| 4 | 6.51a,b | 3.91a,b | 1.18 | 0.0044a,b | 0.0439a,b,c |
| 5 | 7.82b | 3.32b | 1.14 | 0.0055a | 0.0162b,c |
| 6 | 7.83b | 3.70a,b | 1.13 | 0.0031a,b | 0.0404a,b,c |
| 7 | 7.30a,b | 3.35b | 1.26 | 0.0038a,b | 0.0291a,b,c |
| 8 | 6.80a,b | 3.88a,b | 1.28 | 0.0015b | 0.0372a,b,c |
| 9 | 6.15a | 4.85a | 1.42 | 0.0041a,b | 0.0409a,b,c |
| 10 | 6.15a | 3.88a,b | 1.16 | 0.0020b | 0.0281a,b,c |
| 11 | 6.18a | 3.77a,b | 1.44 | 0.0034a,b | 0.0375a,b,c |
| 12 | 6.93a,b | 3.75a,b | 1.62 | 0.0038a,b | 0.0244a,b,c |
| 13 | 6.50a,b | 4.09a,b | 1.27 | 0.0031a,b | 0.0194b,c |
| SEM | 0.1882 | 0.1433 | 0.0471 | 0.0003 | 0.0030 |
a,b,cMeans within the same column with different letters differ significantly (P < 0.05 for lowercase and P < 0.01 for capital letter). IMF: intramuscular fat content; TC: total collagen; SC: soluble collagen; SEM: standard error of means.
Partial correlation analysis of BET, CLA, Met-Cr, and CS with IMF.
| Items | Partial correlation coefficient |
|
|
|---|---|---|---|
|
| 0.9133 | 3.8846 | 0.0178 |
|
| -0.8912 | 3.4031 | 0.0272 |
|
| -0.7079 | 1.7361 | 0.1576 |
|
| -0.8987 | 3.5493 | 0.0238 |
|
| 0.9432 | 4.9151 | 0.0080 |
|
| 0.7420 | 1.9171 | 0.1277 |
|
| 0.7984 | 2.2965 | 0.0833 |
|
| -0.9087 | 3.7713 | 0.0196 |
X 1: BET dosage; X2: CLA dosage; X3: Met-Cr dosage; X4: CS dosage.
Partial correlation analysis of BET, CLA, Met-Cr, and CS with fat content among muscle cells.
| Items | Partial correlation coefficient |
|
|
|---|---|---|---|
|
| 1 | 360.7014 | 0.0001 |
|
| -1 | 216.4755 | 0.0001 |
|
| -1 | 245.1577 | 0.0001 |
|
| 1 | 186.0659 | 0.0001 |
|
| 1 | 219.1888 | 0.0001 |
|
| 1 | 245.0954 | 0.0001 |
|
| -1 | 345.0792 | 0.0001 |
|
| 1 | 326.4331 | 0.0001 |
|
| -1 | 282.3371 | 0.0001 |
|
| -0.9995 | 32.73 | 0.0009 |
X 1: BET dosage; X2: CLA dosage; X3: Met-Cr dosage; X4: CS dosage.
Partial correlation analysis of BET, CLA, Met-Cr, and CS with lipid drop content inside muscle cells.
| Items | Partial correlation coefficient |
|
|
|---|---|---|---|
|
| -0.9921 | 11.1837 | 0.0015 |
|
| 0.9891 | 9.4953 | 0.0025 |
|
| 0.9923 | 11.3058 | 0.0015 |
|
| -0.9929 | 11.7877 | 0.0013 |
|
| -0.992 | 11.1408 | 0.0015 |
|
| 0.9494 | 4.2744 | 0.0235 |
|
| -0.9076 | 3.0583 | 0.0551 |
|
| 0.9916 | 10.8253 | 0.0017 |
|
| -0.9923 | 11.3524 | 0.0015 |
X 1: BET dosage; X2: CLA dosage; X3: Met-Cr dosage; X4: CS dosage.
Partial correlation analysis of BET, CLA, Met-Cr, and CS with TC.
| Items | Partial correlation coefficient |
|
|
|---|---|---|---|
|
| 0.7924 | 1.8370 | 0.1635 |
|
| 0.9956 | 14.9653 | 0.0006 |
|
| 0.9959 | 15.5295 | 0.0006 |
|
| 0.9855 | 8.2219 | 0.0038 |
|
| -0.9939 | 12.7838 | 0.0010 |
|
| -0.9943 | 13.1847 | 0.0009 |
|
| -0.9701 | 5.6480 | 0.0110 |
|
| -0.9952 | 14.3193 | 0.0007 |
|
| -0.9951 | 14.2705 | 0.0007 |
X 1: BET dosage; X2: CLA dosage; X3: Met-Cr dosage; X4: CS dosage.
Partial correlation analysis of BET, CLA, Met-Cr, and CS with SC.
| Items | Partial correlation coefficient |
|
|
|---|---|---|---|
|
| 0.9953 | 14.5274 | 0.0007 |
|
| -0.9956 | 15.0790 | 0.0006 |
|
| -0.9864 | 8.4992 | 0.0034 |
|
| 0.9308 | 3.6019 | 0.0367 |
|
| -0.9808 | 7.1192 | 0.0057 |
|
| -0.9827 | 7.5030 | 0.0049 |
|
| 0.7853 | 1.7935 | 0.1708 |
|
| 0.9962 | 16.1102 | 0.0005 |
|
| 0.9849 | 8.0589 | 0.0040 |
X 1: BET dosage; X2: CLA dosage; X3: Met-Cr dosage; X4: CS dosage.
Pearson correlation analysis between contents of IMF, TC, and SC in muscle.
| Items | Correlation coefficient |
|
|---|---|---|
| IMF-TC | -0.0961 | 0.3934 |
| IMF-SC | 0.2149 | 0.0540∗ |
| TC-SC | 0.2001 | 0.0733∗ |
∗ P < 0.10 represents a light correlation.
Partial correlation analysis of IMF, TC, and SC content in muscle.
| Items | Correlation coefficient |
|
|---|---|---|
| IMF-TC | -0.1454 | 0.2041 |
| IMF-SC | 0.2401 | 0.0343∗ |
| TC-SC | 0.2271 | 0.0456∗ |
∗ P < 0.05 represents a significant difference.